In this study, we investigated this issue by transcriptome sequencing of patient-derived angiosarcoma cells (ISO-HAS), identifying a novel fusion gene NUP160-SLC43A3 found to be expressed in 9 of 25 human angiosarcoma specimens that were examined.     ///    NUP160-SLC43A3 is a novel recurrent fusion oncogene in angiosarcoma.. 